141 filings
Page 2 of 8
8-K
yxmxy0aviokf
9 Jun 23
Submission of Matters to a Vote of Security Holders
5:11pm
424B5
fe1ubgab agvkjv
31 May 23
Prospectus supplement for primary offering
5:19pm
EFFECT
72rbq9w4mducl3t00tl
30 May 23
Notice of effectiveness
12:15am
CORRESP
3s7qztch 1ushq8w5
24 May 23
Correspondence with SEC
12:00am
UPLOAD
4971ko td02harkx74x
18 May 23
Letter from SEC
12:00am
8-K
gs4p5q rreztkm4hhq
11 May 23
Milestone Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Corporate Update
7:25am
S-8
fkqb142
28 Apr 23
Registration of securities for employees
5:10pm
ARS
mv6bcg60m398gm2dzfm9
28 Apr 23
Annual report to shareholders
5:01pm
DEFA14A
8sts3ntq
28 Apr 23
Additional proxy soliciting materials
4:20pm
8-K
shn 9xzcglnc
31 Mar 23
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9:29am
8-K
s32vd vy28g
29 Mar 23
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Corporate Update
9:21am
8-K
xvjp tvyox90
28 Mar 23
Milestone Pharmaceuticals Announces $125 Million Strategic Financing with RTW Investments to Support the Advancement of Etripamil for PSVT
7:00am
8-K
8dmj fi6ns46o0
27 Mar 23
Entry into a Material Definitive Agreement
5:17pm
8-K
05zibg sjgdqj5
10 Mar 23
Regulation FD Disclosure
5:26pm
8-K
5t04plxtjsizvy4c2
7 Mar 23
Regulation FD Disclosure
9:12am